# Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

> **NCT07343401** · — · COMPLETED · sponsor: **Alexandria University** · enrollment: 40 (actual)

## Conditions studied

- Sarcoidosis Lung

## Interventions

- **PROCEDURE:** lymph node biopsy

## Key facts

- **NCT ID:** NCT07343401
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07343401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07343401, "Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07343401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*